In short. Active eczema, a rosacea flare, recent isotretinoin, an open infection: the skin states that rule out both options for now.

Key points

  • Skin that reacts to products, to heat or to weather but is not currently inflamed can often be treated, with a lighter plan, longer intervals and a slower schedule.
  • The distinction is made by looking at the skin rather than by asking the patient whether it is sensitive, because the two descriptions call for opposite responses.

Some skin should not be treated with either option on this site, at least not now. The reasons are clinical rather than cautious, and a patient declined for one of them should know what would have to change.

Skin that is currently inflamed

Active eczema, psoriasis in the treatment area, a rosacea flare or any dermatitis means the skin is already inflamed. Adding a controlled injury to inflamed skin increases the risk of a poor result and, in particular, of pigment change. The inflammation is treated and allowed to settle first, and the plan is then made for skin that is calm. This is a delay rather than an exclusion.

Sensitive is not the same as inflamed

Skin that reacts to products, to heat or to weather but is not currently inflamed can often be treated, with a lighter plan, longer intervals and a slower schedule. The distinction is made by looking at the skin rather than by asking the patient whether it is sensitive, because the two descriptions call for opposite responses.

Skin that is infected or broken

An open infection, an active cold sore, broken skin or a wound in the treatment area rules out both options until it has healed. Treating over an infection spreads it and risks scarring. An active cold sore is a reason to postpone rather than to proceed with antiviral cover, because cover reduces the risk of a flare rather than treating one already present.

Medicines and conditions that change healing

A course of isotretinoin thins the skin and reduces the activity of the oil glands, and skin treated while it is still affected heals less predictably. The interval depends on the dose and duration and is a question for both clinicians together. Medicines that affect clotting, some immunosuppressants, and conditions that slow wound healing belong in the assessment rather than in a footnote. So does a keloid tendency, which does not rule out treatment but changes the depth that is wise.

What is left when treatment is not available

Often something is. A pigmentary problem that cannot be treated with a peel or a laser is frequently managed with topical treatment and sun protection. A problem that is actually structural — a scar, a deep crease or loose skin — may belong to a surgical assessment rather than to either option here. Being told a treatment is not suitable is not the same as being told nothing can be done.

Reasons to postpone rather than proceed

  • Active eczema, psoriasis or a rosacea flare in the area to be treated.
  • An open infection, broken skin, or a cold sore that is active at the time of treatment.
  • A course of isotretinoin that has not yet been completed, or a healing problem that has not been assessed.

None of these is permanent, and each resolves or is treated in time. What matters is that the answer comes from looking at your skin rather than from the diary. The rosacea pages cover one of the commonest reasons to wait, the autoimmune skin pages cover another, and a second opinion is reasonable if you have been told different things by different clinics.

Related reading

Frequently asked questions

Why does isotretinoin change the plan?

It reduces the activity of the oil glands and thins the skin, and skin treated with a peel or a laser while it is still affected heals less predictably and scars more readily. The interval that is advised depends on the dose and how long it was taken, and it is a question for the prescribing clinician and the treating clinician together rather than a fixed rule. It is a temporary exclusion rather than a permanent one.

Can I have treatment during a rosacea flare?

No. A flare means the skin is already inflamed, and adding a controlled injury to inflamed skin increases the risk of a poor result and of pigment change. The flare is treated and allowed to settle first, and the plan is then made for skin that is calm. Some patients with rosacea are treated successfully with conservative settings once the skin is stable, and others are better served by other treatments.

Is sensitive skin the same as inflamed skin?

No, and the distinction matters. Sensitive skin reacts to products and to heat but is not currently inflamed, and it can often be treated with a lighter plan, longer intervals and a slower schedule. Inflamed skin — eczema, rosacea, an infection, or broken skin — is a reason to wait. A clinic that treats the two as the same thing is either over-treating one or under-treating the other.

Risks & Limitations

  • Both options work by injuring the skin deliberately, and pigment change is the risk they share. The risk rises with depth and is materially greater in darker skin tones, and conservative settings there are the clinical plan rather than a compromise.
  • Post-inflammatory pigment change may take months to settle and may not settle completely. Treating it is harder than preventing it, and treating it with a further injury carries its own risk.
  • Deeper treatment leaves skin open rather than flaking. Infection is a real risk while the skin is open, and an untreated infection can lead to scarring that is permanent.
  • A cold sore flare can be triggered by either option in a patient who carries the virus. Antiviral cover before treatment reduces the risk rather than treating an outbreak that has already begun.
  • Scarring after resurfacing is uncommon and is more likely after a deeper treatment, after an infection, or in a patient with a keloid tendency.
  • Healing takes as long as it takes. Redness after resurfacing lasts for weeks and fades over months, and no clinician can shorten it or promise a date at which the skin will look unremarkable.
  • Neither option reverses sun damage permanently. Pigment can return, the skin continues to age, and a result that is not protected with sun avoidance and sunscreen will not hold.
  • Neither option tightens loose skin or repositions tissue that has descended. Those are surgical findings, and a plan that promises them with a peel or a laser has promised something the depth cannot deliver.

When to Seek Care

  • Increasing pain, spreading redness, warmth or swelling in the treated area, particularly with a fever.
  • Discharge that changes in colour or smell, or a wound that is not closing as expected.
  • A cold sore outbreak after treatment, which needs antiviral treatment rather than time.
  • A treated area becoming darker or lighter than the surrounding skin, because early pigment change is easier to manage.
  • A firm, raised or thickening area in the treated skin, or a scar beginning to overgrow.
  • Blistering, crusting or a burn that is not healing — contact the treating team the same day.

References & Further Reading

  • American Academy of Dermatology (AAD) — chemical peeling and laser resurfacing guidance
  • International Society of Aesthetic Plastic Surgery (ISAPS) — global standards of practice
  • National Institute for Health and Care Excellence (NICE, UK) — relevant guidance
  • Cochrane Library — systematic reviews in skin resurfacing and pigment disorders

Medically reviewed by Ke He, MD (何锞), Deputy Director & Head of Skin & Laser Aesthetics. Last reviewed: 19 September 2026.

This page is patient education, not medical advice, and it does not cite individual studies. Discuss your own case with a qualified clinician. To arrange an assessment at Chongqing West District Hospital, see Contact & Consultation.